Symptom Interactions in Cancer and Immune Disorders (R21)
Post Date
March 28th 2008
Application Due Date
May 7th 2011
Funding Opportunity Number
PA-08-122
CFDA Number(s)
93.361
93.399
Funding Instrument Type(s)
Grant
Funding Activity Categories
Eligibility Categories
State Governments
County Governments
City or Township Governments
Special District Governments
Independent School Districts
Public and State Controlled Institutions of Higher Education
Federally Recognized Native American Tribal Governments
Public Housing Authorities or Indian Housing Authorities
Non-Federally Recognized Native American Tribal Organizations
Non-Profits With 501 (c) (3) Status With The IRS (Except Higher Education Institutions)
Non-Profits Without 501 (c) (3) Status With The IRS (Except Higher Education Institutions)
Private Institutions of Higher Education
For-Profit Organizations (Except Small Businesses)
Small Businesses
Other
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions Eligible Agencies of the Federal Government Faith-based or Community-based Organizations Hispanic-serving Institutions Historically Black Colleges and Universities (HBCUs) Indian/Native American Tribal Governments (Other than Federally Recognized) Non-domestic (non-U.S.) Entities (Foreign Organizations) Regional Organizations Tribally Controlled Colleges and Universities (TCCUs) U.S. Territory or Possession
Funding
-
Award Range:
$None - $200000
Grant Description
-Purpose. This funding opportunity announcement (FOA) issued by the National Institute of Nursing Research (NINR),ÊNational Cancer Institute (NCI), National Institute on Aging (NIA), National Institutes of Health (NIH), solicits grant applications from applicant organizations that propose to (a) identify and assess biobehavioral interactions among two or more related and co-occurring symptoms; (b) characterize mechanisms and pathways underlying the symptom interactions; (c) elucidate the level of interaction necessary for categorization as a symptom cluster; and/or (d) design and test interventions targeted to interacting or clustered symptoms that are hypothesized to lead to beneficial patient outcomes. A rationale for the choice of symptoms is needed, not just co-occurrence of two or more symptoms, and they must be associated with a target disease or syndrome or its treatment. Studies at any point in the disease trajectory, or during the survivorship period are encouraged. -Mechanism of Support. This FOA will utilize the R21 grant mechanism and runs in parallel with a FOA of identical scientific scope, PA-08-121, that encourages applications under the R01 grant mechanism. -Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications.
Contact Information
-
Agency
Department of Health and Human Services
-
Office:
National Institutes of Health
-
Agency Contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV -
Agency Mailing Address:
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
- Agency Email Address:
- More Information:
Get A Free Grant Assistance Kit
To start your application for a free grant package go to: